The study also found that: Nearly 90% of Juniper patients lost at least 5% of their body weight Nearly 60% of Juniper patients lost at least 10% of their body weight at 32 weeks One-quarter of Juniper patients lost at least 15% of their body weight at 32 weeks What this shows is that even though GLP-1 medications are often described as a silver bullet for obesity, patients achieve better outcomes when they also receive personalised diet, exercise and medical guidance from practitioners to help them change lifestyle habits in the long term
Healthy fatslike monounsaturated and omega-3 fatty acidshave been shown to boost GLP-1 levels, help regulate appetite, and support sustainable weight loss (Cole, 2025)
In this article, well cover everything about semaglutide weight loss
The Germany semaglutide market is growing as the country has a well-structured healthcare system and a large number of people with type 2 diabetes and obesity
While uncomfortable, this side effect reflects the medication's intended action on gut hormones that control digestion and appetite
Nature 639 , 985994 (2025)